Walvax Biotechnology Co., Ltd. (SHE:300142)

Walvax Biotechnology Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 5, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	20,072	19,320	37,601	64,274	89,423	59,516
Market Cap Growth	-3.22%	-48.62%	-41.50%	-28.12%	50.25%	19.33%
Enterprise Value	18,977	18,563	36,117	62,959	88,584	58,587
Last Close Price	12.55	12.07	23.47	40.11	56.05	38.43
PE Ratio	1359.82	135.90	89.66	88.21	209.06	59.33
Forward PE	53.40	37.75	42.75	54.68	56.13	42.78
PS Ratio	7.90	6.85	9.14	12.64	25.82	20.25
PB Ratio	1.86	1.68	3.30	5.85	8.94	7.58
P/TBV Ratio	2.34	2.31	4.57	8.15	11.16	9.54
P/FCF Ratio	29.69	39.71	199.74	582.65	-	-
P/OCF Ratio	18.89	18.64	33.16	53.50	126.79	521.18
EV/Sales Ratio	7.46	6.58	8.78	12.38	25.58	19.93
EV/EBITDA Ratio	68.40	47.89	32.22	44.27	95.49	51.04
EV/EBIT Ratio	-	773.04	43.46	53.63	111.82	57.22
EV/FCF Ratio	28.07	38.16	191.86	570.72	-	-
Debt / Equity Ratio	0.05	0.04	0.07	0.04	0.03	0.01
Debt / EBITDA Ratio	1.74	1.19	0.70	0.32	0.34	0.03
Debt / FCF Ratio	0.71	1.01	4.28	4.19	-	-
Asset Turnover	0.18	0.19	0.27	0.35	0.30	0.35
Inventory Turnover	0.96	0.83	0.74	0.72	0.60	1.02
Quick Ratio	2.21	2.63	2.37	2.24	2.07	3.00
Current Ratio	2.82	2.98	2.73	2.55	2.37	3.36
Return on Equity (ROE)	-0.80%	1.52%	4.57%	8.94%	6.74%	17.93%
Return on Assets (ROA)	-0.52%	0.10%	3.36%	5.06%	4.25%	7.68%
Return on Capital (ROIC)	-0.64%	0.12%	4.39%	6.74%	5.44%	9.44%
Return on Capital Employed (ROCE)	-	0.20%	6.70%	9.90%	7.60%	12.50%
Earnings Yield	0.07%	0.74%	1.11%	1.13%	0.48%	1.69%
FCF Yield	3.37%	2.52%	0.50%	0.17%	-0.45%	-0.49%
Dividend Yield	0.08%	0.08%	0.04%	0.03%	0.05%	0.18%
Payout Ratio	300.44%	28.80%	4.76%	6.88%	19.48%	3.16%
Buyback Yield / Dilution	0.64%	0.06%	0.21%	-1.93%	-0.90%	-1.37%
Total Shareholder Return	0.72%	0.15%	0.26%	-1.91%	-0.85%	-1.18%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.